# US 2008/0305541 A1 · Recombinant vectors for use in position-independent transgene expression within chromatin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305541 A1
- Document ID: US20080305541A1
- Status: Published application
- Kind: A1
- Application number: 11/879,542
- Filed: 2007-07-17
- Published: 2008-12-11
- Earliest claimed: 2003-05-23
- Assignees: University of Washington
- Inventors: Anton Krumm; Wendy Gombert
- Web page: https://patentgrep.com/patent/US20080305541A1

## CPC

- C12N 15/822: {Reducing position variability, e.g. by the use of scaffold attachment region/matrix attachment region (SAR/MAR); Use of SAR/MAR to regulate gene expression}
- C12N 15/86: Viral vectors
- C12N 2740/13043: viral genome or elements thereof as genetic vector
- C12N 2830/40: being an insulator
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The embodiments of the present invention are directed to discrete, cis-acting regulatory elements that include a barrier element, an insulating element, a silencing element, and matrix attachment regions (“MARs”). Additional embodiments of the present invention are directed to nucleic acid molecules that are useful for facilitating stable transgene expression within a chromatin environment. Additional embodiments of the present invention are directed to recombinant expression vectors including nucleic acid molecules of the present invention that can be incorporated into artificial chromosomes, eukaryotic cell-lines, non-human transgenic animals, and transgenic plants, to improve recombinant protein production in a broad range of eukaryotic hosts, and pharmaceutical compositions including nucleic acid molecules of the present invention that are also useful for gene therapy in the treatment of various genetic diseases.

## Claims

### Claim 1

A method for protecting a non-c-myc-gene DNA polymer from regulation by regulatory regions of a chromosomal sequence into which the DNA polymer is inserted and for preventing the DNA polymer from being inactivated within a heterochromatin region within the chromosomal sequence, the method comprising:
generating a protected DNA polymer by appending to the non-c-myc-gene DNA polymer one or more of:
a c-myc-locus insulating element,
a c-myc-locus-insulating-element barrier element,
a c-myc-locus-insulating-element CTCF sub-fragment,
a c-myc-locus-insulating-element S1 silencing element,
a c-myc-locus-insulating-element S2 silencing element,
a DNA polymer containing the c-myc-locus insulating element,
a DNA polymer containing the c-myc-locus-insulating-element barrier element,
a DNA polymer containing the c-myc-locus-insulating-element CTCF sub-fragment,
a DNA polymer containing the c-myc-locus-insulating-element S1 silencing element,
a DNA polymer containing the c-myc-locus-insulating-element S2 silencing element; and
inserting the protected DNA polymer into the chromosomal sequence.

### Claim 2 (depends on 1)

The method of claim 1 further including appending, to the 5′ end of the protected DNA polymer, an additional DNA polymer containing a 5′ c-myc nuclear attachment region prior to inserting the generated protected DNA polymer into the chromosomal sequence.

### Claim 3 (depends on 1)

The method of claim 1 further including appending, to the 3′ end of the protected DNA polymer, an additional DNA polymer containing a 3′ c-myc nuclear attachment region prior to inserting the generated protected DNA polymer into the chromosomal sequence.

### Claim 4 (depends on 1)

The method of claim 1 wherein the protected DNA polymer is an expression vector that is introduced into a host cell by one of:
receptor-mediated gene delivery;
microinjection;
liposome fusion;
electroporation;
calcium-phosphate precipitation.

### Claim 5 (depends on 4)

The method of claim 4 wherein introduction by receptor-mediated gene delivery involves incorporation of the protected DNA polymer into a viral vector, the viral vector one of:
an adenoviral vector;
a Moloney-murine-leukemia-virus vector;
a poliovirus-replicon-based viral vector;
a herpes-virus-based viral vector;
a mumps-virus-based viral vector;
a Sindbis-virus-based viral vector;
a vaccinia-virus-based viral vector; and
a herpes-virus-based viral vector;

### Claim 6 (depends on 1)

A protected DNA polymer generated by the method of claim 1.

### Claim 7

A method for protecting a non-c-myc-gene chromosomal subsequence within a chromosomal sequence from regulation by neighboring regulatory elements within the chromosomal sequence and from incorporation into heterochromatin, the chromosomal sequence and the chromosomal subsequence both having 3′ and 5′ ends, the method comprising:
selecting, as a protecting component, one or more of
a c-myc-locus insulating element,
a c-myc-locus-insulating-element barrier element,
a c-myc-locus-insulating-element CTCF sub-fragment,
a c-myc-locus-insulating-element S1 silencing element,
a c-myc-locus-insulating-element S2 silencing element,
a DNA polymer containing the c-myc-locus insulating element,
a DNA polymer containing the c-myc-locus-insulating-element barrier element,
a DNA polymer containing the c-myc-locus-insulating-element CTCF sub-fragment,
a DNA polymer containing the c-myc-locus-insulating-element S1 silencing element,
a DNA polymer containing the c-myc-locus-insulating-element S2 silencing element; and
inserting the protecting component into the chromosomal sequence at a position that protects the non-c-myc-gene chromosomal subsequence within the chromosomal sequence from regulation by neighboring regulatory elements of the chromosomal sequence and from incorporation into heterochromatin.

### Claim 8 (depends on 7)

The method of claim 7 wherein the protecting component is inserted closer to the 5′ end of the chromosomal sequence than the 5′ end of the chromosomal subsequence

### Claim 9 (depends on 8)

The method of claim 8 further including:
inserting a 5′ c-myc nuclear attachment region into the chromosomal sequence at a position within the chromosomal sequence closer to the 5′ end of the chromosomal sequence than the 5′ end of the protecting component.

### Claim 10 (depends on 7)

The method of claim 7 wherein the protecting component is inserted closer to the 3′ end of the chromosomal sequence than the 3′ end of the chromosomal subsequence

### Claim 11 (depends on 8)

The method of claim 8 further including:
inserting a 3′ c-myc nuclear attachment region into the chromosomal sequence at a position within the chromosomal sequence closer to the 5′ end of the chromosomal sequence than the 3′ end of the protecting component.

### Claim 12 (depends on 8)

A chromosomal subsequence protected by the method of claim 8.
